Boston Scientific (BSX) Income from Non-Controlling Interests (2023 - 2026)
Boston Scientific's (BSX) quarterly Income from Non-Controlling Interests came in at -$2.0 million in Q1 2026, little changed year-on-year from -$2.0 million in Q1 2025, and little changed quarter-over-quarter from -$2.0 million in Q4 2025.
Boston Scientific (BSX) Income from Non-Controlling Interests (2023 - 2026) Analysis & Trends
Boston Scientific has disclosed Income from Non-Controlling Interests across 4 years of filings, most recently posting -$2.0 million for Q1 2026.
- Income from Non-Controlling Interests for Q1 2026 came in at -$2.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.0 million (up 25.0% YoY), and the FY2025 annual result was -$6.0 million, up 25.0% from the prior year.
- Income from Non-Controlling Interests came in at -$2.0 million for Q1 2026 at Boston Scientific, roughly flat from -$2.0 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$1.0 million in Q4 2023 to a low of -$4.0 million in Q4 2024.
- The 4-year median for Income from Non-Controlling Interests is -$2.0 million (2024), against an average of -$2.0 million.
- Across the five-year window, Income from Non-Controlling Interests plunged 300.0% in 2024 and jumped 50.0% in 2025, its largest moves.
- Boston Scientific's Income from Non-Controlling Interests stood at -$1.0 million in 2023, then slumped by 300.0% to -$4.0 million in 2024, then surged by 50.0% to -$2.0 million in 2025, then changed by 0.0% to -$2.0 million in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$2.0 million (Q1 2026), -$2.0 million (Q4 2025), and -$2.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 6.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -5.85 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 22.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 100,000.00 |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.00 Mn |
| Dec 31, 2025 | -2.00 Mn |
| Jun 30, 2025 | -2.00 Mn |
| Mar 31, 2025 | -2.00 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Dec 31, 2023 | -1.00 Mn |